| 1 | [SID48416019] | Active | | | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 48416019 | | CID | 30751 | | Outcome | Active | | BioAssay | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database | | AID | 1195 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID103749729] | Unspecified | | | Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset [AID588220, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103749729 | | CID | 30751 | | Outcome | Unspecified | | BioAssay | Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset | | AID | 588220 | | BioAssay type | Literature | | Target | | | PubMed | 20020916 | | Data Table |  |
|
| 3 | [SID136949088] | Inactive | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID136949088] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID136949088] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) [AID652017, Type: screening] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) | | AID | 652017 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID136949088] | Inactive | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID136949088] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID136949088] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID686964, Type: screening] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide | | AID | 686964 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID124893767] | Inactive | Potency | | Biochemical firefly luciferase enzyme assay for NPC [AID624030, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 124893767 | | CID | 30751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Biochemical firefly luciferase enzyme assay for NPC | | AID | 624030 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 10 | [SID136949088] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 11 | [SID136949088] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 12 | [SID124893767] | Inactive | Potency | | qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 124893767 | | CID | 30751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors | | AID | 624173 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table |  |
|
| 13 | [SID136949088] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) [AID652067, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) | | AID | 652067 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 14 | [SID136949088] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) [AID652126, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) | | AID | 652126 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 15 | [SID136949088] | Inactive | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 136949088 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 16 | [SID124893767] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 124893767 | | CID | 30751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|
| 17 | [SID124893767] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 124893767 | | CID | 30751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 18 | [SID124893767] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 124893767 | | CID | 30751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 19 | [SID124893767] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 124893767 | | CID | 30751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 20 | [SID103749729] | Inactive | | | Inhibition of bovine brain MAOA [AID409958, Type: Literature] | Amine oxidase [flavin-containing] A [gi:124028637] |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103749729 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Inhibition of bovine brain MAOA | | AID | 409958 | | BioAssay type | Literature | | Target | Amine oxidase [flavin-containing] A [gi:124028637] | | PubMed | 18834112 | | Data Table |  |
|
| 21 | [SID103749729] | Inactive | | | Inhibition of bovine brain MAOB [AID409960, Type: Literature] | Amine oxidase [flavin-containing] B [gi:124028638] |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103749729 | | CID | 30751 | | Outcome | Inactive | | BioAssay | Inhibition of bovine brain MAOB | | AID | 409960 | | BioAssay type | Literature | | Target | Amine oxidase [flavin-containing] B [gi:124028638] | | PubMed | 18834112 | | Data Table |  |
|
| 22 | [SID92308227] | Inactive | | | A screen for compounds that inhibit liver stage malaria [AID624349, Type: other] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 92308227 | | CID | 30751 | | Outcome | Inactive | | BioAssay | A screen for compounds that inhibit liver stage malaria | | AID | 624349 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|